Answers are grounded in this paper and cite their sources.
Infectious osteomyelitis presents a coupled therapeutic challenge: deep-seated biofilms require effective local eradication, whereas infection-associated bone defects require tissue regeneration. Here, we developed an injectable nanozyme hydrogel that spatially anchors therapeutic components within the bone marrow cavity and enables noninvasive temporal regulation of catalytic antibacterial activity. PtNi nanoparticles were deposited onto an FeSr metal-organic framework (MOF), providing a magnetic field-responsive catalytic platform, a porous reservoir for ciprofloxacin (CIP), and a degradable source of Sr²⁺. The CIP-loaded FeSr MOF@PtNi was coated with azide-functionalized macrophage membranes and subsequently reacted with a dibenzocyclooctyne-functionalized, quaternary ammonium-modified hyperbranched polymer through copper-free azide-alkyne cycloaddition, forming a hydrogel in situ after intramedullary injection. This process improved the local retention of the nanozyme and associated therapeutic components. Upon alternating magnetic field stimulation, the retained nanozyme generated more than 10-fold higher reactive oxygen species levels compared to the unstimulated control. The generated oxidative stress compromised methicillin-resistant S. aureus (MRSA) biofilms and killed MRSA, while CIP and the cationic polymer provided complementary antibacterial effects. The hydrogel reduced MRSA biofilm biomass by 79.5% and decreased viable MRSA by more than 99.9% in vitro and in vivo. Meanwhile, FeSr MOF degradation released Sr²⁺, promoting osteoblast differentiation and bone regeneration. This spatially anchored and temporally regulated platform couples magnetically controlled antibiofilm therapy with subsequent bone repair for infectious osteomyelitis.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: